InventisBio Future Growth
Future criteria checks 2/6
InventisBio is forecast to grow earnings and revenue by 58.4% and 66.9% per annum respectively. EPS is expected to grow by 50.7% per annum. Return on equity is forecast to be -6.6% in 3 years.
Key information
58.4%
Earnings growth rate
50.7%
EPS growth rate
| Biotechs earnings growth | 43.4% |
| Revenue growth rate | 66.9% |
| Future return on equity | -6.6% |
| Analyst coverage | Low |
| Last updated | 06 Nov 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 366 | -75 | -2 | -52 | 2 |
| 12/31/2025 | 292 | -135 | -127 | -163 | 2 |
| 12/31/2024 | 90 | -324 | -237 | -245 | 2 |
| 9/30/2024 | 78 | -348 | -367 | -363 | N/A |
| 6/30/2024 | 120 | -330 | -298 | -293 | N/A |
| 3/31/2024 | 194 | -249 | -321 | -316 | N/A |
| 12/31/2023 | 186 | -284 | -314 | -308 | N/A |
| 9/30/2023 | 127 | -340 | -389 | -381 | N/A |
| 6/30/2023 | 80 | -426 | -500 | -501 | N/A |
| 3/31/2023 | N/A | -481 | -466 | -459 | N/A |
| 12/31/2022 | N/A | -483 | -485 | -477 | N/A |
| 9/30/2022 | N/A | -476 | -399 | -392 | N/A |
| 6/30/2022 | N/A | -416 | -324 | -305 | N/A |
| 3/31/2022 | N/A | -411 | -311 | -282 | N/A |
| 12/31/2021 | N/A | -358 | -279 | -252 | N/A |
| 12/31/2020 | N/A | -1,053 | -203 | -197 | N/A |
| 12/31/2019 | 55 | -95 | -31 | -22 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688382 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 688382 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 688382 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 688382's revenue (66.9% per year) is forecast to grow faster than the CN market (13.9% per year).
High Growth Revenue: 688382's revenue (66.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688382 is forecast to be unprofitable in 3 years.